Blood Conservation Strategy during Cardiac Valve Surgery in Jehovah’s Witnesses: a Comparative Study with Non-Jehovah’s Witnesses
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: We compared the clinical outcomes of cardiac valve surgery in adult Jehovah’s Witness patients refusing blood transfusion to those in non-Jehovah’s Witness patients without any transfusion limitations. Methods: From 2005 to 2014, 25 Jehovah’s Witnesses (JW group) underwent cardiac valve surgery using a blood conservation strategy. Twenty-five matched control patients (non-JW group) were selected according to sex, age, operation date, and surgeon. Both groups were managed according to general guidelines of anticoagulation for valve surgery. Results: The operative mortality rate was 4.0% in the JW group and 0% in the non-JW group (p = 1.000). There was no difference in postoperative major complications between the groups (p = 1.000). The overall survival rate at 5 and 10 years was 85.6% ± 7.9% and 85.6% ± 7.9% in the JW group, respectively, and 100.0% ± 0.0% and 66.7% ± 27.2% in the non-JW group (p = 0.313). The valve-related morbidity-free survival rates (p = 0.625) and late morbidity-free survival rates (p = 0.885) were not significantly different between the groups. Conclusions: Using a perioperative strategy for blood conservation, cardiac valve surgery without transfusion had comparable clinical outcomes in adult patients. This blood conservation strategy could be broadly applied to major surgeries with careful perioperative care.
Abstract
Background: We compared the clinical outcomes of cardiac valve surgery in adult Jehovah’s Witness patients refusing blood transfusion to those in non-Jehovah’s Witness patients without any transfusion limitations. Methods: From 2005 to 2014, 25 Jehovah’s Witnesses (JW group) underwent cardiac valve surgery using a blood conservation strategy. Twenty-five matched control patients (non-JW group) were selected according to sex, age, operation date, and surgeon. Both groups were managed according to general guidelines of anticoagulation for valve surgery. Results: The operative mortality rate was 4.0% in the JW group and 0% in the non-JW group (p = 1.000). There was no difference in postoperative major complications between the groups (p = 1.000). The overall survival rate at 5 and 10 years was 85.6% ± 7.9% and 85.6% ± 7.9% in the JW group, respectively, and 100.0% ± 0.0% and 66.7% ± 27.2% in the non-JW group (p = 0.313). The valve-related morbidity-free survival rates (p = 0.625) and late morbidity-free survival rates (p = 0.885) were not significantly different between the groups. Conclusions: Using a perioperative strategy for blood conservation, cardiac valve surgery without transfusion had comparable clinical outcomes in adult patients. This blood conservation strategy could be broadly applied to major surgeries with careful perioperative care.
참고문헌 (25)
- Goodnough LT, "Bloodless medicine: clinical care without allogeneic blood transfusion", Transfusion, 43, pp.668~676 (2003)
- Jo KI, "Eight-year experience of bloodless surgery at a tertiary care hospital in Korea", Transfusion, 53, pp.948~954 (2013)
- Rosengart TK, "Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah’s Witness patients: implications for a “bloodless” surgical technique", J Am Coll Surg, 184, pp.618~629 (1997)
- Helm RE, "Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion", Ann Thorac Surg, 65, pp.125~136 (1998)
- Spahn DR, "Eliminating blood transfusions:new aspects and perspectives", Anesthesiology, 93, pp.242~255 (2000)
- Juraszek A, "Results of open heart surgery in Jehovah’s Witnesses patients", J Cardiovasc Surg (Torino), 50, pp.247~250 (2009)
- Pompei E, "Mid-term clinical outcomes in cardiac surgery of Jehovah’s witnesses", J Cardiovasc Med (Hagerstown), 11, pp.170~174 (2010)
- Moraca RJ, "Strategies and outcomes of cardiac surgery in Jehovah’s Witnesses", J Card Surg, 26, pp.135~143 (2011)
- Emmert MY, "How good patient blood management leads to excellent outcomes in Jehovah’s witness patients undergoing cardiac surgery", Interact Cardiovasc Thorac Surg, 12, pp.183~188 (2011)
- Vaislic CD, "Outcomes in cardiac surgery in 500consecutive Jehovah’s Witness patients: 21 year experience", J Cardiothorac Surg, 7, pp.95~ (2012)
- Marshall L, "Short term outcomes after cardiac surgery in a Jehovah’s Witness population: an institutional experience", Heart Lung Circ, 21, pp.101~104 (2012)
- Jassar AS, "Cardiac surgery in Jehovah’s Witness patients: ten-year experience", Ann Thorac Surg, 93, pp.19~25 (2012)
- Stamou SC, "Comparisons of cardiac surgery outcomes in Jehovah’s versus non-Jehovah’s Witnesses", Am J Cardiol, 98, pp.1223~1225 (2006)
- Reyes G, "Bloodless cardiac surgery in Jehovah’s witnesses:outcomes compared with a control group", Rev Esp Cardiol, 60, pp.727~731 (2007)
- Bhaskar B, "Comparison of outcome in Jehovah’s Witness patients in cardiac surgery: an Australian experience", Heart Lung Circ, 19, pp.655~659 (2010)
- Pattakos G, "Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation", Arch Intern Med, 172, pp.1154~1160 (2012)
- Casati V, "Intraoperative low-volume acute normovolemic hemodilution in adult open-heart surgery", Anesthesiology, 97, pp.367~373 (2002)
- Shapira OM, "Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume", Ann Thorac Surg, 65, pp.724~730 (1998)
- Rosengart TK, "Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements", J Thorac Cardiovasc Surg, 115, pp.426~438 (1998)
- Akins CW, "Guidelines for reporting mortality and morbidity after cardiac valve interventions", Eur J Cardiothorac Surg, 33, pp.523~528 (2008)
- Ott DA, "Cardiovascular surgery in Jehovah’s Witnesses. Report of 542 operations without blood transfusion", JAMA, 238, pp.1256~1258 (1977)
- Habib RH, "Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed?", J Thorac Cardiovasc Surg, 125, pp.1438~1450 (2003)
- Ranucci M, "Hematocrit on cardiopulmonary bypass and outcome after coronary surgery in nontransfused patients", Ann Thorac Surg, 89, pp.11~17 (2010)
- Karkouti K, "Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery", J Thorac Cardiovasc Surg, 129, pp.391~400 (2005)
- Habib RH, "Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome", Crit Care Med, 33, pp.1749~1756 (2005)